Skip to content
10-Q

Quarterly Report

TYRA BIOSCIENCES, INC. TYRA

0000950170-25-066942

← back to feed
Filed
May 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 5, 2025 53.18M sh
Current Liabilities Q1 2025 · Mar 31, 2025 $14.25M
Current Liabilities Q1 2025 · Dec 31, 2024 $14.59M
Total Liabilities Q1 2025 · Mar 31, 2025 $19.94M
Total Liabilities Q1 2025 · Dec 31, 2024 $20.41M
Current Assets Q1 2025 · Mar 31, 2025 $324.57M
Current Assets Q1 2025 · Dec 31, 2024 $347.46M
Total Assets Q1 2025 · Mar 31, 2025 $343.48M
Total Assets Q1 2025 · Dec 31, 2024 $363.56M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $91.97M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $254.37M
Shares Diluted Q1 2025 · Mar 31, 2024 52.23M sh
Capex Q1 2025 · Mar 31, 2024 $136K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$22.03M
Stockholders Equity Q1 2025 · Mar 31, 2024 $389.88M
Stockholders Equity Q1 2025 · Dec 31, 2023 $204.26M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.35
Eps Basic Q1 2025 · Mar 31, 2024 −$0.35
Rd Expense Q1 2025 · Mar 31, 2024 $17.2M
Net Income Q1 2025 · Mar 31, 2024 −$18.19M
Operating Income Q1 2025 · Mar 31, 2024 −$22.32M